Business Context and Reporting Period
This Form 8-K Current Report was filed by OptimumBank Holdings, Inc. on October 31, 2011, covering events occurring on October 25 and October 27, 2011. The filing details a material definitive agreement with director Moishe Gubin and the completion of a private placement offering to raise capital for the Company and its wholly-owned subsidiary, OptimumBank.
Key Financial Metrics and Capital Transactions
- Private Placement Proceeds: The Company completed an $8.3 million common stock offering on October 27, 2011.
- Shares Issued in Private Placement: 20,639,250 shares sold at $0.40 per share.
- Director Participation: Approximately $1.9 million of the private placement proceeds came from Board of Directors members.
- Proposed Stock Purchase Agreement: Director Moishe Gubin agreed to purchase 6,750,000 newly issued shares for $2.7 million in cash at $0.40 per share.
- Combined Ownership: Upon closing, Gubin is anticipated to own 8,550,000 shares (including 1,800,000 from the private placement), representing approximately 30% of outstanding common stock.
- Use of Proceeds: The Company intends to contribute a substantial amount of net proceeds as new capital to OptimumBank.
Note: This filing does not provide revenue, profit, cash flow, margin, or debt metrics for the reporting period.
Material Changes and Conditions
The primary material change is the execution of the Stock Purchase Agreement with Moishe Gubin, which is subject to specific closing conditions:
- Consummation of the Private Placement (minimum 20,000,000 shares at $0.40 per share, equaling $8 million in proceeds).
- Receipt of required governmental and regulatory approvals, including from the Federal Reserve Board and the Florida Office of Financial Regulation.
- The agreement may be terminated if closing does not occur by February 28, 2012.
Both the Transaction and the Private Placement were conducted as unregistered sales of equity securities in reliance on the exemption provided by Rule 506 of Regulation D.
Guidance, Risks, and Contingencies
The filing contains forward-looking statements regarding the ability to consummate transactions and raise capital. Management highlighted significant risks and contingencies, including:
- Regulatory Approval: Failure to receive necessary approvals from the Federal Reserve Board or state regulators.
- Going Concern: Risks related to the Company's ability to continue as a going concern.
- Capital Adequacy: Inability to raise additional capital on acceptable terms or maintain adequate capital and liquidity levels.
- Operational Risks: Volatility in credit and equity markets, changes in interest rates, and the adequacy of the allowance for loan losses.
- Registration Rights: The Company has agreed to file Form S-3 registration statements for shares sold in both the Transaction and the Private Placement.
Investor Verification Checklist
- Verify the receipt of regulatory approvals from the Federal Reserve Board and the Florida Office of Financial Regulation required to close the Gubin transaction.
- Confirm the final closing date of the Stock Purchase Agreement to ensure it occurs before the February 28, 2012 termination deadline.
- Review the effectiveness of the Form S-3 registration statements filed for the shares sold to Gubin and other investors.
- Assess the Company's current capital adequacy ratios following the injection of the $8.3 million private placement proceeds.
- Monitor any supervisory actions or regulatory orders against OptimumBank that could impact dividend declarations or operations.